OPEN LABEL, NON RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PLATELET RICH PLASMA (PRP) IN ALOPECIA, STRAIE AND ATROPHIC ACNE SCAR.
- Conditions
- Health Condition 1: null- alopecia, atrophic acne scars, striae
- Registration Number
- CTRI/2013/09/003976
- Lead Sponsor
- Gujarat Cancer Society Medical college hospital and research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 20
1.Patients between ages of 18 to 70 years.
2.Patients with androgenic alopecia or scaring alopecia who are not taking any other treatment.
3.Patients with atrophic scars >1 in no. and not taking any other treatment.
4.Patients with straie >1 in no.
5.Otherwise healthy patients.
6.Non-pregnant, non-lactating women
1.Patients below age of 18 or above the age of 70 yr.
2.Patients who were on oral isotretinoin in last 6 months.
3.Patients who underwent any surgical modality of treatment in last 2 month.
4.Patients who have history of keloid formation or koebnerization for vitiligo.
5.Patients with atrophic scars or striae <2 in no.
6.Patients who are on oral immunosuppressive drugs.
7.Patients having history of any systemic diseases like- renal disease, liver disease, diabetes, tuberculosis, HIV etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method alopecia primary outcome: increase in hair density, increase hair growth. <br/ ><br>acne scar primary outcome:rejuvenation of acne scars,decrease depth of scars <br/ ><br>striae:decrease in thickness and length, decrease erythemaTimepoint: every month for six months
- Secondary Outcome Measures
Name Time Method adverse events, minimum time duration for starting and maximum effects.Timepoint: every month for six months